Citalopram hydrochloride

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance

BrBzGCp2 is a Glyoxalase 1 (GLO1) inhibitor, with a GC 50 of 4.23 μM in HL-60 cells. BrBzGCp2 possesses antitumor and neuroprotective activityIn VivoGLO1 inhibition by BrBzGCp2 increases center time in the OF test, without changing distance

CGP 36742 is a selective GABA B receptor antagonist that can penetrate the blood–brain barrier after peripheral administration, with an IC 50 of 32 μM. CGP 36742 is useful in treatment of depressionIC50&amp: Target:IC50: 32 μM (GABA B ).

This compound is an internal standard of Citalopram, as well as an uptake inhibitor of serotonin (5-HT).

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under

Citalopram.

Citalopram.

Citalopram.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the